home / stock / bnigf / bnigf news

BNIGF News and Press, Beroni Group Ltd From 08/30/21

Stock Information
Company Name: Beroni Group Ltd
Stock Symbol: BNIGF
Market: OTC
Website: beronigroup.com
Menu
BNIGF BNIGF Quote BNIGF Short BNIGF News BNIGF Articles BNIGF Message Board
Get BNIGF Alerts

News, Short Squeeze, Breakout and More Instantly...
BNIGF - Beroni Group Limited (BNIGF) Latest Clinical Study of SARS-CoV-2 Antigen Test Kit

Sydney, Australia (ABN Newswire) - Beroni Group Limited (OTCMKTS:BNIGF) (NSX:BTG), an Australia-based biopharmaceutical enterprise, announced the latest clinical study of its SARS-CoV-2 Antigen Test Kit (Colloidal Gold Method) demonstrated an overall sensitivity of 95% and specificity of 100%...
BNIGF - Beroni Initiates Manufacture of its Novel, Potential Anti-Cancer Drug PENAO

NEW YORK and SYDNEY, Australia, Aug. 18, 2021 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni”), an Australia-based diversified biopharmaceutical enterprise, announced that PENAO Pty Ltd, its majority-owned, Sydney-based anti-cancer drug development company,...

BNIGF - Beroni inks MOU with tella to collaborate in immunotherapy for cancer treatment

Beroni Group (BNIGF) announces that it has signed a Memorandum of Understanding ((MOU)) with tella to collaborate in the field of immunotherapy for cancer treatment.Beroni is an Australia-based diversified biopharmaceutical enterprise, while tella is a Japanese company conducti...

BNIGF - Beroni Group Signs MoU with tella, Inc to Collaborate in Immunotherapy for Cancer Treatment

NEW YORK and SYDNEY, Australia, May 28, 2021 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an Australia-based diversified biopharmaceutical enterprise today announced that it has signed a Memorandum of Understanding with t...
BNIGF - Beroni Group Issues US$2 Million of Convertible Notes to Fund Research and Development Plans

NEW YORK and SYDNEY, Australia, May 28, 2021 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an Australia-based diversified biopharmaceutical enterprise today announced that it has raised US$2 million via the issue of conver...

BNIGF - Beroni Group Limited (BNIGF) Collaboration with tella Inc for Cancer Treatment

Sydney, Australia (ABN Newswire) - Beroni Group (OTCMKTS:BNIGF) (NSX:BTG), an Australia-based diversified biopharmaceutical enterprise today announced that it has signed a Memorandum of Understanding with tella, Inc. to collaborate in the field of immunotherapy for cancer treatment. tella i...

BNIGF - Beroni Group Limited (BNIGF) SARS-CoV-2 Antigen Test Kit Received Export Permit

Sydney, Australia (ABN Newswire) - Beroni Group (OTCMKTS:BNIGF) (NSX:BTG), an Australia-based diversified biopharmaceutical enterprise today announced that it has received the notification that its SARS-CoV-2 Antigen Test Kit (Colloidal Gold Method) is granted authorization for export. As...
BNIGF - Beroni Group's SARS-CoV-2 Antigen Test Kit (Colloidal Gold Method) Has Received Export Permit

NEW YORK and SYDNEY, Australia, April 27, 2021 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an Australia-based diversified biopharmaceutical enterprise today announced that it has received the notification that its SARS...

BNIGF - Beroni Group Limited (BNIGF) Appointment of Non-Executive Director

Sydney, Australia (ABN Newswire) - Beroni Group (OTCMKTS:BNIGF) (NSX:BTG) an international diversified biopharmaceutical enterprise focused on the research, development, innovation and commercialization of therapies and products for treatment of global diseases, is pleased to announce that it...

BNIGF - Beroni Group Limited (BNIGF) Acquires Majority Interest in Anti-Cancer Drug Development Company

Sydney, Australia (ABN Newswire) - Beroni Group (OTCMKTS:BNIGF) (NSX:BTG), an Australia-based diversified biopharmaceutical enterprise today announces that it has completed its majority acquisition of the Sydney-based anticancer drug development company, PENAO Pty Ltd. As a result of this acq...
Previous 10 Next 10